Division of Adolescent Medicine, Department of Pediatrics, The Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
Rainbow Services, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Pediatrics. 2022 Sep 1;150(3). doi: 10.1542/peds.2022-057494.
Evidence suggests that children and adolescents with avoidant/restrictive food intake disorder (ARFID) have heterogeneous clinical presentations. To use latent class analysis (LCA) and determine the frequency of various classes in pediatric patients with ARFID drawn from a 2-year surveillance study.
Cases were ascertained using the Canadian Pediatric Surveillance Program methodology from January 1, 2016, to December 31, 2017. An exploratory LCA was undertaken with latent class models ranging from 1 to 5 classes.
Based on fit statistics and class interpretability, a 3-class model had the best fit: Acute Medical (AM), Lack of Appetite (LOA), and Sensory (S). The probability of being classified as AM, LOA, and S was 52%, 40.7%, and 6.9%, respectively. The AM class was distinct for increased likelihood of weight loss (92%), a shorter length of illness (<12 months) (66%), medical hospitalization (56%), and heart rate <60 beats per minute (31%). The LOA class was distinct for failure to gain weight (97%) and faltering growth (68%). The S class was distinct for avoiding certain foods (100%) and refusing to eat because of sensory characteristics of the food (100%). Using posterior probability assignments, a mixed group AM/LOA (n = 30; 14.5%) had characteristics of both AM and LOA classes.
This LCA suggests that ARFID is a heterogeneous diagnosis with 3 distinct classes corresponding to the 3 subtypes described in the literature: AM, LOA, and S. The AM/LOA group had a mixed clinical presentation. Clinicians need to be aware of these different ARFID presentations because clinical and treatment needs will vary.
有证据表明,患有回避/限制型食物摄入障碍(ARFID)的儿童和青少年临床表现存在异质性。本研究使用潜在类别分析(LCA),并从为期 2 年的监测研究中确定患有 ARFID 的儿科患者中各种类别的频率。
本病例通过加拿大儿科监测计划的方法,于 2016 年 1 月 1 日至 2017 年 12 月 31 日确定。进行了潜在类别分析,使用的潜在类别模型从 1 到 5 个类别不等。
根据拟合统计数据和类别可解释性,3 类模型具有最佳拟合度:急性医学(AM)、食欲不振(LOA)和感觉(S)。被归类为 AM、LOA 和 S 的概率分别为 52%、40.7%和 6.9%。AM 类的特点是体重减轻的可能性更高(92%)、疾病持续时间更短(<12 个月)(66%)、医疗住院(56%)和心率<60 次/分钟(31%)。LOA 类的特点是体重增加失败(97%)和生长停滞(68%)。S 类的特点是避免某些食物(100%)和因食物感官特征而拒绝进食(100%)。使用后验概率分配,AM/LOA 混合组(n=30;14.5%)具有 AM 和 LOA 两类的特征。
本 LCA 表明,ARFID 是一种异质性诊断,有 3 个不同的类别,对应于文献中描述的 3 种亚型:AM、LOA 和 S。AM/LOA 组表现出混合临床特征。临床医生需要意识到这些不同的 ARFID 表现,因为临床和治疗需求会有所不同。